Lyell Immunopharma（LYEL）股票预测
最新价—
涨跌—
AI预测: LYEL
该股票目前没有最新的AI预测。
AI发布下一个交易日、周末和月末的目标价。涨跌幅以最新价格计算。这些是统计估计，而非投资建议。
Premium会员可查看该股票及所有其他股票的1天、1周和1个月AI目标价。
解锁Premium关于该公司
Lyell Immunopharma specializes in cell therapy, focusing on the reprogramming of T-lymphocytes for the treatment of solid tumors. The company’s technologies are applicable regardless of biological targets and their associated pathways, and are utilized in chimeric antigen receptor (CAR) T-cell therapy, tumor-infiltrating lymphocyte (TIL) therapy, and T-cell receptor (TCR) therapy. Lyell Immunopharma is currently developing a pipeline of products designed to deliver comprehensive therapeutic effects across various forms of solid tumors that are difficult to treat.
